| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V77343 | [DPro5] Corticotropin Releasing Factor, human, rat TFA | [DPro5] Corticotropin Releasing Factor, human, rat TFA is a selective agonist of corticotropin-releasing factor/hormone R2 (CRH-R2). | |
|
V132476 | CRF1 receptor antagonist-2 | 441060-02-2 | CRF1 receptor antagonist-2 is an orally effective, blood-brain barrier-crossing CRF1 receptor antagonist with an IC50 value of 4 nM on CHO-K1 cell membranes and 7 nM on rat brain cell membranes. |
|
V74556 | K41498 | 434938-41-7 | K41498 is a selective CRF2 receptor antagonist (inhibitor) with Kis of 0.66 nM, 0.62 nM and 425 nM for human CRF2α, CRF2β and CRF1 receptors respectively. |
|
V81690 | Urotensin I TFA (Catostomus urotensin I TFA) | Urotensin I (Catostomus urotensin I) TFA is a CRF-like peptide that could be utilized as a CRF receptor agonist. | |
|
V3636 | Verucerfont | 885220-61-1 | Verucerfont (also known as GSK561679 and NBI77860) is a novel and potent antagonist of corticotropin-releasing factor receptor 1 (CRF1) with IC50s of ~6.1, >1000 and >1000 nM for CRF1, CRF2, and CRF-BP, respectively. |